Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • TA307
  • Published: 
Download guidance (PDF)

5 Implementation

5.1 NICE has developed a costing statement explaining the resource impact of this guidance to help organisations put this guidance into practice.